Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 02, 2026
DataAggregated Company Financials
Companies7
- 7D10.5%
- 3M7.3%
- 1Y-7.0%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 10%, driven by gains from Oxford Nanopore Technologies of 13%. Meanwhile, Oxford BioDynamics actually underperformed within the industry, shrinking 41% in the last week. In the past year, the industry is down 7.0%. As for the next few years, earnings are expected to grow by 57% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 02 Jul 2026 | UK£1.5b | UK£323.1m | -UK£164,731,254.00 | 1274.4x | -9x | 4.6x |
| Sat, 30 May 2026 | UK£1.6b | UK£323.0m | -UK£166,018,254.00 | 1248.1x | -9.7x | 5x |
| Mon, 27 Apr 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.1x | 4.3x |
| Wed, 25 Mar 2026 | UK£1.3b | UK£324.0m | -UK£161,423,254.00 | 8.5x | -8.3x | 4.2x |
| Fri, 20 Feb 2026 | UK£1.5b | UK£304.7m | -UK£159,511,254.00 | 12.4x | -9.6x | 5x |
| Sun, 18 Jan 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 7.5x | -10.7x | 5.6x |
| Tue, 16 Dec 2025 | UK£1.4b | UK£304.4m | -UK£160,881,254.00 | 8.5x | -8.7x | 4.6x |
| Thu, 13 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 8.2x | -9.4x | 5.1x |
| Sat, 11 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.9x | -10x | 5.4x |
| Mon, 08 Sep 2025 | UK£1.8b | UK£313.5m | -UK£158,190,352.00 | 6.5x | -11.3x | 5.7x |
| Wed, 06 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -14.4x | 7.9x |
| Fri, 04 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.9x | -10.1x | 5.6x |
| Sun, 01 Jun 2025 | UK£1.6b | UK£319.6m | -UK£190,958,890.00 | 5.6x | -8.2x | 4.9x |
| Tue, 29 Apr 2025 | UK£1.6b | UK£313.6m | -UK£192,087,556.40 | 11.2x | -8.4x | 5.1x |
| Thu, 27 Mar 2025 | UK£1.5b | UK£315.7m | -UK£186,310,515.95 | 5.8x | -7.9x | 4.7x |
| Sat, 22 Feb 2025 | UK£1.7b | UK£306.4m | -UK£195,106,167.60 | 6.9x | -8.9x | 5.7x |
| Mon, 20 Jan 2025 | UK£2.1b | UK£307.8m | -UK£196,207,193.76 | 7.1x | -10.5x | 6.7x |
| Wed, 18 Dec 2024 | UK£2.1b | UK£306.2m | -UK£194,946,070.32 | 7.7x | -10.8x | 6.8x |
| Fri, 15 Nov 2024 | UK£1.9b | UK£305.7m | -UK£193,463,506.72 | 10.4x | -10.1x | 6.4x |
| Sun, 13 Oct 2024 | UK£2.0b | UK£304.4m | -UK£192,350,536.90 | 10.6x | -10.4x | 6.6x |
| Tue, 10 Sep 2024 | UK£2.0b | UK£293.5m | -UK£192,442,081.20 | 12.1x | -10.4x | 6.9x |
| Thu, 08 Aug 2024 | UK£1.9b | UK£297.0m | -UK£189,319,026.11 | 12.3x | -9.9x | 6.3x |
| Sat, 06 Jul 2024 | UK£1.6b | UK£295.5m | -UK£189,930,390.09 | 11.7x | -8.2x | 5.3x |
| Mon, 03 Jun 2024 | UK£1.6b | UK£295.6m | -UK£189,808,553.55 | 11.3x | -8.6x | 5.5x |
| Wed, 01 May 2024 | UK£1.5b | UK£292.9m | -UK£189,023,379.29 | 6973.2x | -7.7x | 5x |
| Fri, 29 Mar 2024 | UK£1.8b | UK£319.1m | -UK£191,397,787.59 | 69.8x | -9.2x | 5.5x |
| Sun, 25 Feb 2024 | UK£1.9b | UK£285.8m | -UK£189,209,049.14 | 6964.3x | -10.3x | 6.8x |
| Tue, 23 Jan 2024 | UK£2.9b | UK£450.2m | -UK£176,575,158.00 | 61.5x | -16.2x | 6.4x |
| Thu, 21 Dec 2023 | UK£3.2b | UK£450.1m | -UK£174,131,391.00 | 52.7x | -18.2x | 7x |
| Sat, 18 Nov 2023 | UK£3.0b | UK£455.8m | -UK£168,941,726.00 | 50.3x | -18x | 6.7x |
| Mon, 16 Oct 2023 | UK£2.9b | UK£458.7m | -UK£165,688,739.00 | 51.1x | -17.6x | 6.3x |
| Wed, 13 Sep 2023 | UK£3.1b | UK£440.4m | -UK£166,942,738.00 | 67.5x | -18.4x | 7x |
| Fri, 11 Aug 2023 | UK£3.4b | UK£476.1m | -UK£126,508,300.00 | 70.6x | -27.1x | 7.2x |
| Sun, 09 Jul 2023 | UK£2.9b | UK£476.3m | -UK£124,539,981.00 | 66.1x | -23.4x | 6.1x |
Price to Earnings Ratio
-23.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.6x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 0.24% | |
| Healthcare | -0.43% | |
| Life Sciences | 10.48% | |
| Clinical Research and Equipment | 10.48% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£1.31 | 12.8% +UK£145.0m | -7.8% | PS5.7x | |
| DXRX Diaceutics | UK£1.46 | 0.7% +UK£846.7k | 29.2% | PE1274.4x | |
| PRM Proteome Sciences | UK£0.017 | 9.3% +UK£491.0k | -45.7% | PS1.5x |